Ask AI
Bill115th CongressFiled Nov 7, 2017Crime and Law Enforcement
H.R. 4275

Empowering Pharmacists in the Fight Against Opioid Abuse Act

Bill journey · stage 2 of 5

Under committee review

Filed
Comm.
Floor
Both
Law

What it doesSummary passed house amended (Jun 12, 2018)

Empowering Pharmacists in the Fight Against Opioid Abuse Act

(Sec. 2) This bill requires the Department of Health and Human Services (HHS) to develop and disseminate training programs and materials on: (1) the circumstances under which a pharmacist may refuse to fill a controlled substance prescription suspected to be fraudulent, forged, or indicative of abuse or diversion; and (2) federal requirements related to such refusal.

HHS must seek input from relevant stakeholders.

What just happenedJun 13, 2018

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Who’s behind it

Rep. DeSaulnier, Mark [D-CA-11](D-CA)Sponsor
12 cosponsors1 D11 R
Read on Congress.gov
12cosponsors2committees15actions1related bills6subjects
  1. Jun 13, 2018IntroReferral

    Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Health, Education, Labor, and Pensions Committee
  2. Jun 12, 2018FloorH38310

    Motion to reconsider laid on the table Agreed to without objection.

  3. Jun 12, 2018FloorH37300

    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5066)

  4. Jun 12, 2018Floor8000

    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5066)

  5. Jun 12, 2018FloorH8D000

    DEBATE - The House proceeded with forty minutes of debate on H.R. 4275.

  6. Jun 12, 2018FloorH30000

    Considered under suspension of the rules. (consideration: CR H5066-5067)

  7. Jun 12, 2018FloorH30300

    Mr. Walden moved to suspend the rules and pass the bill, as amended.

  8. May 9, 2018Committee

    Ordered to be Reported (Amended) by Voice Vote.

    Energy and Commerce Committee
  9. May 9, 2018Committee

    Committee Consideration and Mark-up Session Held.

    Energy and Commerce Committee
  10. Apr 25, 2018Committee

    Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .

    Health Subcommittee
  11. Apr 25, 2018Committee

    Subcommittee Consideration and Mark-up Session Held.

    Health Subcommittee
  12. Nov 10, 2017Committee

    Referred to the Subcommittee on Health.

    Health Subcommittee
  13. Nov 7, 2017IntroReferralH11100

    Referred to the House Committee on Energy and Commerce.

    Energy and Commerce Committee
  14. Nov 7, 2017IntroReferralIntro-H

    Introduced in House

  15. Nov 7, 2017IntroReferral1000

    Introduced in House

Passed House amendedJun 12, 201836

Empowering Pharmacists in the Fight Against Opioid Abuse Act

(Sec. 2) This bill requires the Department of Health and Human Services (HHS) to develop and disseminate training programs and materials on: (1) the circumstances under which a pharmacist may refuse to fill a controlled substance prescription suspected to be fraudulent, forged, or indicative of abuse or diversion; and (2) federal requirements related to such refusal.

HHS must seek input from relevant stakeholders.

Introduced in HouseNov 7, 2017

Empowering Pharmacists in the Fight Against Opioid Abuse Act

This bill requires the Drug Enforcement Administration (DEA) to develop and disseminate training programs and materials on: (1) the circumstances under which a pharmacist may refuse to fill a controlled substance prescription suspected to be fraudulent, forged, or indicative of abuse or diversion; and (2) federal requirements related to such refusal.

The DEA must seek input from relevant stakeholders.

Empowering Pharmacists in the Fight Against Opioid Abuse Act — Informed